Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007
- PMID: 25872471
- PMCID: PMC5705063
- DOI: 10.1002/cncr.29371
Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007
Abstract
Background: The extent to which improvements over time in breast cancer survival are related to earlier detection by mammography or to more effective treatments is not known.
Methods: At a comprehensive cancer care center, the authors conducted a retrospective cohort study of women ages 50 to 69 years who were diagnosed with invasive breast cancer (stages I through III) and were followed over 3 periods (1990-1994, 1995-1999, and 2000-2007). Data were abstracted from patient charts and included detection method, diagnosis, treatment, and follow-up for vital status in the institutional breast cancer registry (n = 2998). The method of detection was categorized as patient or physician detected or mammography detected. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for 5-year disease-specific survival in relation to detection method and treatment factors, and differences in survival were analyzed using the Kaplan-Meier method.
Results: Fifty-eight percent of breast cancers were mammography detected, and 42% were patient or physician detected; 56% of tumors were stage I, 31% were stage II, and 13% were stage III. The average length of follow-up was 10.71 years. The combined 5-year disease-specific survival rate was 89% from 1990 to 1994, 94% from 1995 to 1999, and 96% from 2000 to 2007 (P < .001). In an adjusted model, mammography detection (HR, 0.43; 95% CI, 0.27-0.70), hormone therapy (HR, 0.47; 95% CI, 0.30-0.75), and taxane-containing chemotherapy (HR, 0.61; 95% CI, 0.37-0.99) were significantly associated with a decreased risk of disease-specific mortality.
Conclusions: Better breast cancer survival over time was related to mammography detection, hormone therapy, and taxane-containing chemotherapy. Treatment improvements alone are not sufficient to explain the observed survival improvements over time.
Keywords: adjuvant chemotherapy; breast cancer; mammography; regression modeling; survival.
© 2015 American Cancer Society.
Figures
Similar articles
-
Improved prognosis of women aged 75 and older with mammography-detected breast cancer.Radiology. 2014 Dec;273(3):686-94. doi: 10.1148/radiol.14140209. Epub 2014 Aug 5. Radiology. 2014. PMID: 25093690
-
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. APMIS. 2014. PMID: 25046200 Review.
-
Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.Stat Methods Med Res. 2008 Dec;17(6):643-63. doi: 10.1177/0962280207087309. Epub 2008 Apr 29. Stat Methods Med Res. 2008. PMID: 18445697 Review.
-
Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.J Natl Cancer Inst. 2005 Aug 17;97(16):1195-203. doi: 10.1093/jnci/dji239. J Natl Cancer Inst. 2005. PMID: 16106024
-
Risk for distant recurrence of breast cancer detected by mammography screening or other methods.JAMA. 2004 Sep 1;292(9):1064-73. doi: 10.1001/jama.292.9.1064. JAMA. 2004. PMID: 15339900
Cited by
-
Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.BJS Open. 2024 May 8;8(3):zrae040. doi: 10.1093/bjsopen/zrae040. BJS Open. 2024. PMID: 38758563 Free PMC article.
-
Self-detection remains a primary means of breast cancer detection in Beijing, China.Transl Breast Cancer Res. 2022 Apr 8;4:27. doi: 10.21037/tbcr-22-2. eCollection 2023. Transl Breast Cancer Res. 2022. PMID: 38751468 Free PMC article.
-
The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA).J Cancer Surviv. 2024 Apr 26. doi: 10.1007/s11764-024-01608-0. Online ahead of print. J Cancer Surviv. 2024. PMID: 38664296
-
Breast cancer outcomes based on method of detection in community-based breast cancer registry.Breast Cancer Res Treat. 2024 Jan;203(2):215-224. doi: 10.1007/s10549-023-07092-x. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878149
-
Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute's experience.BMC Womens Health. 2023 Jun 21;23(1):330. doi: 10.1186/s12905-023-02445-6. BMC Womens Health. 2023. PMID: 37344800 Free PMC article.
References
-
- Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–1792. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical